Posts by DAY Vision
Dilon Launches US FDA Cleared Clinical Trial for Use of MarginProbe® in Breast Cancer Surgery
[vc_row][vc_column][vc_column_text]Dilon Devices, Ltd. today announced the launch of a pivotal clinical trial of the MarginProbe™ intraoperative, real-time, positive margin detection system, following U.S. Food and Drug Administration (FDA) investigational device exemption (IDE) approval of its protocol during breast cancer surgery. With the FDA IDE approval in place, Dune is launching a nationwide U.S. clinical trial…
Read MoreRandomized, Controlled Multicenter Trial Demonstrates Safety and Clinical Benefit, Significant Reduction in Repeat Surgeries Enabled by Dune’s MarginProbe®
[vc_row][vc_column][vc_column_text]Company Opens US Office to Spearhead North American Operations Caesarea, Israel-Jan. 7, 2008 – Dilon Devices announces significant new clinical developments surrounding the company’s novel breast cancer assessment probe, currently in investigational use. Results from a recent randomized clinical trial in 11 medical centers in Israel have underscored the safety and clinical benefit of the…
Read MorePredictors of Re-Excision Among Women Undergoing Breast-Conserving Surgery for Cancer
[vc_row][vc_column][vc_column_text]Waljee JF, et al. Ann Surg Oncol. 2008;15(5):1297-1303. View Study[/vc_column_text][/vc_column][/vc_row]
Read MoreMargins in Breast-Conserving Therapy: Have We Lost Sight of the Big Picture?
[vc_row][vc_column][vc_column_text]Morrow M. Expert Rev Anticancer Ther. 2008;8(8):1193-1196. View Study [/vc_column_text][/vc_column][/vc_row]
Read MoreA Prospective, Randomized, Controlled, Multicenter Study of a Real-Time, Intraoperative Probe for Positive Margin Detection in Breast-Conserving Surgery.
[vc_row][vc_column][vc_column_text]View Study[/vc_column_text][/vc_column][/vc_row]
Read More